Literature DB >> 25921556

Analysis of the Reasons for Non-Uptake of Predictive Testing for Huntington's Disease in Spain: A Qualitative Study.

Jesús Rivera-Navarro1, Esther Cubo2, Natividad Mariscal2.   

Abstract

Children of persons affected by Huntington's disease (HD) have a 50% chance of inheriting the disease. Genetic testing in Spain is offered to individuals (presymptomatic test) or mothers of fetuses (prenatal) who run the risk of suffering from HD. The objective of this study is to analyze the factors that influence the decisions of adult children of persons affected with HD regarding predictive testing. A qualitative research methodology was used involving 4 focus groups (FGs) made up of adult children of persons with HD in different cities in Spain. The results of the study showed that over half of the focus group participants were inclined to decline genetic testing. The main explanatory determinants for taking or not taking the predictive test are: Maturity of the individual at risk, which was directly related to age; Ability to cope with a positive test result; Experience of living with HD sufferers; Information about testing and psychological support; Attitude of the family; Social visibility of genetic testing; Personality and temperament of each subject at risk of HD. These results imply that these factors should be analyzed in more detail in quantitative studies in order to help the Spanish Department of Health understand why some children of parents with HD decline genetic testing, so that they may and apply these data when creating specific policy regarding this issue.

Entities:  

Keywords:  Explanatory factors; Genetic testing; Huntington’s disease; Qualitative method

Mesh:

Year:  2015        PMID: 25921556     DOI: 10.1007/s10897-015-9840-x

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  66 in total

1.  Personal factors associated with reported benefits of Huntington disease family history or genetic testing.

Authors:  Janet K Williams; Cheryl Erwin; Andrew Juhl; James Mills; Bradley Brossman; Jane S Paulsen
Journal:  Genet Test Mol Biomarkers       Date:  2010-08-19

Review 2.  Huntington's Disease.

Authors:  Francis O Walker
Journal:  Semin Neurol       Date:  2007-04       Impact factor: 3.420

Review 3.  Quality assessment of genetic counseling process in the context of presymptomatic testing for late-onset disorders: a thematic analysis of three review articles.

Authors:  Milena Paneque; Jorge Sequeiros; Heather Skirton
Journal:  Genet Test Mol Biomarkers       Date:  2011-08-05

4.  Witchcraft and Huntington's disease: a salutary history of societal and medical stigmatisation.

Authors:  Samantha Loi; Edmond Chiu
Journal:  Australas Psychiatry       Date:  2012-09-26       Impact factor: 1.369

5.  In their own words: reports of stigma and genetic discrimination by people at risk for Huntington disease in the International RESPOND-HD study.

Authors:  Janet K Williams; Cheryl Erwin; Andrew R Juhl; Michelle Mengeling; Yvonne Bombard; Michael R Hayden; Kimberly Quaid; Ira Shoulson; Sandra Taylor; Jane S Paulsen
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-09       Impact factor: 3.568

Review 6.  A systematic review of the incidence and prevalence of long-term neurological conditions in the UK.

Authors:  Thomas Hoppitt; Hardev Pall; Mel Calvert; Paramjit Gill; Guiqing Yao; Jill Ramsay; Gill James; Jacky Conduit; Cath Sackley
Journal:  Neuroepidemiology       Date:  2010-11-17       Impact factor: 3.282

Review 7.  The incidence and prevalence of Huntington's disease: a systematic review and meta-analysis.

Authors:  Tamara Pringsheim; Katie Wiltshire; Lundy Day; Jonathan Dykeman; Thomas Steeves; Nathalie Jette
Journal:  Mov Disord       Date:  2012-06-12       Impact factor: 10.338

8.  Predictive testing for Huntington disease in Canada: adverse effects and unexpected results in those receiving a decreased risk.

Authors:  M Huggins; M Bloch; S Wiggins; S Adam; O Suchowersky; M Trew; M Klimek; C R Greenberg; M Eleff; L P Thompson
Journal:  Am J Med Genet       Date:  1992-02-15

9.  Psychological well-being in persons affected by Huntington's disease: a comparison of at-risk, prodromal, and symptomatic groups.

Authors:  Lauren Zeranski Chisholm; Kaitlin T Flavin; Jane S Paulsen; Rebecca Ready
Journal:  J Health Psychol       Date:  2012-05-08

10.  Perceptions of genetic discrimination among people at risk for Huntington's disease: a cross sectional survey.

Authors:  Yvonne Bombard; Gerry Veenstra; Jan M Friedman; Susan Creighton; Lauren Currie; Jane S Paulsen; Joan L Bottorff; Michael R Hayden
Journal:  BMJ       Date:  2009-06-09
View more
  1 in total

1.  Phenotype Characterization of HD Intermediate Alleles in PREDICT-HD.

Authors:  Nancy R Downing; Spencer Lourens; Isabella De Soriano; Jeffrey D Long; Jane S Paulsen
Journal:  J Huntingtons Dis       Date:  2016-12-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.